Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Brenda B. Cirincione
Observed names:
B CIRINCIONE,
B. B. Cirincione,
B. Cirincione,
B.B. Cirincione,
Brenda B Cirincione,
Brenda Cirincione
show all 6
Institution:
Bristol-Myers Squibb (United States)
Observed institutions:
Bristol-Myers Squibb (United States),
EDF Energy North America,
Vertex Pharmaceuticals (United States),
University at Buffalo, State University of New York
OpenAlex ID:
A5043407893
Clinical relevance of anti‐exenatide antibodies: safety, efficacy and cross‐reactivity with long‐term treatment
2012
·
M. S. Fineman
, K. F. Mace
, et al.
·
Diabetes Obesity and Metabolism
·
158
Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing
2010
·
Mark Fineman
, Shawn Flanagan
, et al.
·
Clinical Pharmacokinetics
·
145
Use of Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Phase 2 and 3 Dosing Strategies for Doripenem
2005
·
Sujata M. Bhavnani
, Jeffrey P. Hammel
, et al.
·
Antimicrobial Agents and Chemotherapy
·
125
Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Skin and Skin-Structure Infections
2007
·
A. K. Meagher
, J. A. Passarell
, et al.
·
Antimicrobial Agents and Chemotherapy
·
123
GLP‐1 based therapies: differential effects on fasting and postprandial glucose
2012
·
M.S. Fineman
, B.B. Cirincione
, et al.
·
Diabetes Obesity and Metabolism
·
122
Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Intra-Abdominal Infections
2007
·
J. A. Passarell
, A. K. Meagher
, et al.
·
Antimicrobial Agents and Chemotherapy
·
112
Population Pharmacokinetic Analysis of Linezolid in Patients With Infectious Disease: Application to Lower Body Weight and Elderly Patients
2009
·
Sadahiro Abe
, Koji Chiba
, et al.
·
The Journal of Clinical Pharmacology
·
107
Population Pharmacokinetics of Apixaban in Subjects With Nonvalvular Atrial Fibrillation
2018
·
Brenda Cirincione
, Kenneth Kowalski
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
81
PDF
Population Pharmacokinetics of Tigecycline in Patients with Complicated Intra-Abdominal or Skin and Skin Structure Infections
2006
·
S. A. Van Wart
, J. S. Owen
, et al.
·
Antimicrobial Agents and Chemotherapy
·
73
Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction
2003
·
P. G. Ambrose
, Sujata M Bhavnani
, et al.
·
Journal of Antimicrobial Chemotherapy
·
57
First‐in‐human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS‐962212, a direct, reversible, small molecule factor XIa inhibitor in non‐Japanese and Japanese healthy subjects
2018
·
Vidya Perera
, Joseph M. Luettgen
, et al.
·
British Journal of Clinical Pharmacology
·
56
PDF
Population pharmacokinetics of exenatide
2016
·
Brenda Cirincione
, Donald E. Mager
·
British Journal of Clinical Pharmacology
·
42
PDF
Prophylactic use of anti‐emetic medications reduced nausea and vomiting associated with exenatide treatment: a retrospective analysis of an open‐label, parallel‐group, single‐dose study in healthy subjects
2010
·
C. Ellero
, J. Han
, et al.
·
Diabetic Medicine
·
40
PDF
Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QTc interval in healthy subjects
2012
·
Börje Darpö
, Sager Philip
, et al.
·
British Journal of Clinical Pharmacology
·
35
PDF
Population Pharmacokinetics of Tigecycline in Healthy Volunteers
2007
·
S. A. Van Wart
, B. B. Cirincione
, et al.
·
The Journal of Clinical Pharmacology
·
34
Influence of Meals and Glycemic Changes on QT Interval Dynamics
2017
·
Brenda Cirincione
, Philip T. Sager
, et al.
·
The Journal of Clinical Pharmacology
·
24
PDF
Population Pharmacokinetics of an Extended-Release Formulation of Exenatide Following Single- and Multiple-Dose Administration
2016
·
Brenda Cirincione
, Jeffrey Edwards
, et al.
·
The AAPS Journal
·
23
PDF
Use of a clinically derived exposure–response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpoints
2008
·
Paul G. Ambrose
, Alison K. Meagher
, et al.
·
Diagnostic Microbiology and Infectious Disease
·
22
Challenges in the transition to model-based development
2005
·
Thaddeus H. Grasela
, Jill Fiedler-Kelly
, et al.
·
The AAPS Journal
·
22
PDF
Application of patient population-derived pharmacokinetic–pharmacodynamic relationships to tigecycline breakpoint determination for staphylococci and streptococci
2009
·
Paul G. Ambrose
, Alison K. Meagher
, et al.
·
Diagnostic Microbiology and Infectious Disease
·
19
Population Pharmacokinetics Analysis To Inform Efavirenz Dosing Recommendations in Pediatric HIV Patients Aged 3 Months to 3 Years
2016
·
Man Luo
, Sunny Chapel
, et al.
·
Antimicrobial Agents and Chemotherapy
·
14
PDF
Study Reanalysis Using a Mechanism-Based Pharmacokinetic/Pharmacodynamic Model of Pramlintide in Subjects with Type 1 Diabetes
2012
·
Jing Fang
, Cornelia B. Landersdorfer
, et al.
·
The AAPS Journal
·
14
PDF
Population Pharmacokinetic Model for Gatifloxacin in Pediatric Patients
2007
·
Christopher M. Rubino
, Edmund V. Capparelli
, et al.
·
Antimicrobial Agents and Chemotherapy
·
9
Informatics: The fuel for pharmacometric analysis
2007
·
Thaddeus H. Grasela
, Jill Fiedler-Kelly
, et al.
·
The AAPS Journal
·
8
PDF
Development of a Population Pharmacokinetic Model for Taranabant, a Cannibinoid-1 Receptor Inverse Agonist
2010
·
Xiujiang Li
, Jace Nielsen
, et al.
·
The AAPS Journal
·
7
PDF
Show more works
View as search
Works count:
38
Citation count:
1,501
H-index:
19
I10-index:
22
Year
Topic
Type